342 related articles for article (PubMed ID: 30319637)
1. On the Road to Immunotherapy-Prospects for Treating Head and Neck Cancers With Checkpoint Inhibitor Antibodies.
Ward FJ; Dahal LN; Abu-Eid R
Front Immunol; 2018; 9():2182. PubMed ID: 30319637
[TBL] [Abstract][Full Text] [Related]
2. [Immunotherapy in head and neck cancer].
Kansy B; Hussain T; Mattheis S; Wollenberg B; Brandau S; Lang S
HNO; 2015 Nov; 63(11):797-803. PubMed ID: 26452491
[TBL] [Abstract][Full Text] [Related]
3. [Immune checkpoint inhibitor therapy in advanced head and neck cancer].
Hang W; Xu ZX; Zhang Q; Lu X; Liu G
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 52(1):67-70. PubMed ID: 28104022
[TBL] [Abstract][Full Text] [Related]
4. CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer.
Srivastava RM; Trivedi S; Concha-Benavente F; Gibson SP; Reeder C; Ferrone S; Ferris RL
Clin Cancer Res; 2017 Feb; 23(3):707-716. PubMed ID: 27496866
[TBL] [Abstract][Full Text] [Related]
5. Immune alterations and immunotherapy prospects in head and neck cancer.
Varilla V; Atienza J; Dasanu CA
Expert Opin Biol Ther; 2013 Sep; 13(9):1241-56. PubMed ID: 23789839
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy: Who Is Eligible?
Wang D; Gilbert J; Kim YJ
Otolaryngol Clin North Am; 2017 Aug; 50(4):867-874. PubMed ID: 28755708
[TBL] [Abstract][Full Text] [Related]
7. Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma.
Moy JD; Moskovitz JM; Ferris RL
Eur J Cancer; 2017 May; 76():152-166. PubMed ID: 28324750
[TBL] [Abstract][Full Text] [Related]
8. Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patients.
Chen G; Wu Q; Jiang H; Li Z; Hua X; Hu X; Yu H; Xie C; Zhong Y
J Hematol Oncol; 2020 Dec; 13(1):174. PubMed ID: 33308264
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer.
Whiteside TL; Chikamatsu K; Nagashima S; Okada K
Anticancer Res; 1996; 16(4C):2357-64. PubMed ID: 8816835
[TBL] [Abstract][Full Text] [Related]
10. Immunobiology of head and neck cancer.
Whiteside TL
Cancer Metastasis Rev; 2005 Jan; 24(1):95-105. PubMed ID: 15785875
[TBL] [Abstract][Full Text] [Related]
11. Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer.
Rosewell Shaw A; Porter CE; Watanabe N; Tanoue K; Sikora A; Gottschalk S; Brenner MK; Suzuki M
Mol Ther; 2017 Nov; 25(11):2440-2451. PubMed ID: 28974431
[TBL] [Abstract][Full Text] [Related]
12. Emerging patient-specific treatment modalities in head and neck cancer - a systematic review.
Elicin O; Cihoric N; Vlaskou Badra E; Ozsahin M
Expert Opin Investig Drugs; 2019 Apr; 28(4):365-376. PubMed ID: 30760055
[TBL] [Abstract][Full Text] [Related]
13. Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs.
Cavalieri S; Rivoltini L; Bergamini C; Locati LD; Licitra L; Bossi P
Cancer Treat Rev; 2018 Apr; 65():78-86. PubMed ID: 29574334
[TBL] [Abstract][Full Text] [Related]
14. Precision medicine in head and neck cancer.
Kaidar-Person O; Gil Z; Billan S
Drug Resist Updat; 2018 Sep; 40():13-16. PubMed ID: 30466712
[TBL] [Abstract][Full Text] [Related]
15. Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer.
Ludwig S; Floros T; Theodoraki MN; Hong CS; Jackson EK; Lang S; Whiteside TL
Clin Cancer Res; 2017 Aug; 23(16):4843-4854. PubMed ID: 28400428
[No Abstract] [Full Text] [Related]
16. Current studies of immunotherapy in head and neck cancer.
Dogan V; Rieckmann T; Münscher A; Busch CJ
Clin Otolaryngol; 2018 Feb; 43(1):13-21. PubMed ID: 28464441
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Head and Neck Cancer.
Sim F; Leidner R; Bell RB
Oral Maxillofac Surg Clin North Am; 2019 Feb; 31(1):85-100. PubMed ID: 30449528
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy in head and neck cancer: evidence and perspectives.
Tosoni A; Franceschi E; Pasquini E; Lanese A; Donini E; Foschini MP; Dall'Olio D; Brandes AA
Immunotherapy; 2017 Dec; 9(16):1351-1358. PubMed ID: 29185392
[TBL] [Abstract][Full Text] [Related]
19. Immunity in head and neck cancer.
Schoenfeld JD
Cancer Immunol Res; 2015 Jan; 3(1):12-7. PubMed ID: 25568068
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians.
Outh-Gauer S; Alt M; Le Tourneau C; Augustin J; Broudin C; Gasne C; Denize T; Mirghani H; Fabre E; Ménard M; Scotte F; Tartour E; Badoual C
Cancer Treat Rev; 2018 Apr; 65():54-64. PubMed ID: 29547766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
